// App-Quantinova.ai

: MYOCARDIAL INFARCTION AFTER RECEIVING THE COVID-19 VACCINE IN A PATIENT WITH HIGH RISK FOR THROMBOSIS

Researchers

Presenter

  • Abhiram Challa

Principal Investigators

  • Ameen El-Swais

  • Rhythm Vasudeva

  • Tejasri Polana

  • Hamna Shah

  • Brent Duran

Medical Centers

  • University of Kansas School of Medicine--Wichita Wichita Kansas USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Angiology

Disease

  • Peripheral artery disease

  • Antiphospholipid syndrome

  • Coronary Artery Disease

  • Myocardial infarction

  • Deep vein thrombosis

  • Dyspnea

  • Pulmonary embolism

  • Venous thrombosis

  • Angina

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved